[vc_column width=”1/1″][vc_column width=”1/1″][/vc_column]

Upcoming Market Access Events / Conferences – May 2017

April 26, 2017
-
Market Access News
Read More →
Posted by MORSE Team

ODB Formulary Update – April 2017

April 21, 2017
-
Market Access News
Read More →
Posted by MORSE Team

pCPA Update as of March 31, 2017

April 12, 2017
-
Market Access News
Read More →
Posted by MORSE Team

Introducing the MORSE KEY – a New Reimbursement Events Calendar

April 12, 2017
-
Market Access News, What's New
-
No comments
Read More →
Posted by MORSE Team

pCPA Update as of February 28, 2017

March 16, 2017
-
Market Access News
Read More →
Posted by MORSE Team

Health Canada Guidance Document on the Disclosure of Confidential Business Information – March 10, 2017

March 10, 2017
-
Market Access News
Read More →
Posted by MORSE Team

The pan-Canadian Cancer Drug Funding Sustainability Initiative

March 8, 2017
-
Market Access News
Read More →
Posted by MORSE Team

Terms of Reference for Scientific Advisory Panel on Opioid Use and Contraindications

February 28, 2017
-
Market Access News
Read More →
Posted by MORSE Team

BC Pharmacare Newsletter- February 2017

February 28, 2017
-
Market Access News
Read More →
Posted by MORSE Team

Perspective on the pCPA Hepatitis C Negotiation

February 24, 2017
-
Market Access News
-
No comments
Read More →
Posted by MORSE Team

Alberta Drug Benefit List – March 2017

February 24, 2017
-
Market Access News
Read More →
Posted by MORSE Team

ODB Formulary Update – February 2017

February 24, 2017
-
Market Access News
Read More →
Posted by MORSE Team

The February 2017 Update for Quebec’s List of Medications

February 14, 2017
-
Market Access News
Read More →
Posted by MORSE Team

PMPRB Releases its February 2017 Newsletter

February 13, 2017
-
Market Access News
Read More →
Posted by MORSE Team

pCPA Update as of January 31, 2017

February 9, 2017
-
Market Access News
Read More →
Posted by MORSE Team
MORSE Market Access Signals - Latest in Pharmaceutical Reimbursement